Sana Biotechnology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SANA and other ETFs, options, and stocks.

About SANA

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. 

CEO
Steven D. Harr
CEOSteven D. Harr
Employees
194
Employees194
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2018
Founded2018
Employees
194
Employees194

SANA Key Statistics

Market cap
1.30B
Market cap1.30B
Price-Earnings ratio
-5.15
Price-Earnings ratio-5.15
Dividend yield
Dividend yield
Average volume
2.72M
Average volume2.72M
High today
$5.12
High today$5.12
Low today
$4.85
Low today$4.85
Open price
$4.98
Open price$4.98
Volume
1.10M
Volume1.10M
52 Week high
$6.55
52 Week high$6.55
52 Week low
$1.26
52 Week low$1.26

Stock Snapshot

Sana Biotechnology(SANA) stock is priced at $4.87, giving the company a market capitalization of 1.3B. It carries a P/E multiple of -5.15.

As of 2026-01-23, Sana Biotechnology(SANA) stock has fluctuated between $4.85 and $5.12. The current price stands at $4.87, placing the stock +0.4% above today's low and -5.0% off the high.

The Sana Biotechnology(SANA)'s current trading volume is 1.1M, compared to an average daily volume of 2.72M.

In the last year, Sana Biotechnology(SANA) shares hit a 52-week high of $6.55 and a 52-week low of $1.26.

In the last year, Sana Biotechnology(SANA) shares hit a 52-week high of $6.55 and a 52-week low of $1.26.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own SANA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.